Determinants of response to pentoxifylline therapy in patients with intermittent claudication.
Eighty-three patients receiving pentoxifylline for stable claudication were evaluated to identify factors associated with response to treatment. Patients with isolated aortoiliac occlusive disease and those with arterial occlusive disease of moderate severity were more likely to have an improvement in claudication distance.
Thomas
J H
JH
Department of Surgery, University of Kansas Medical Center, Kansas City 66103.
Swannack
C J
CJ
McAnaw
M
M
Klein
S
S
Kinnaman
M L
ML
Iliopoulos
J I
JI
Hermreck
A S
AS
Pierce
G E
GE
D000328:Adult; D000368:Aged; D001794:Blood Pressure; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000188:drug therapy* / Q000503:physiopathology; D008124:Locomotion; D008297:Male; D008875:Middle Aged; D010146:Pain; D010431:Pentoxifylline / Q000627:therapeutic use*; D013805:Theobromine / Q000031:analogs & derivatives*
D013805:Theobromine; D010431:Pentoxifylline